Nantahala Capital Management »

Aziyo Biologics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 1.7M 2.16
2023-09-30 $2.4M 1.7M 1.43

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Perkins Capital Management
Worth Venture Partners
Vanguard Group
Indie Asset Partners
Millennium Management
Verdence Capital Advisors
Virtu Financial
Us Bancorp
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Aziyo Biologics